SLB, First Solar And 2 Other Stocks Insiders Are Selling
Portfolio Pulse from Avi Kapoor
Insiders from First Solar, Schlumberger, Vertex Pharmaceuticals, and Lattice Semiconductor have recently sold shares. Insider sales can indicate concerns about company prospects or stock overvaluation. Notable sales include First Solar's Chief People and Comm. Officer selling 12,406 shares, Schlumberger's President New Energy selling 38,083 shares, Vertex Pharmaceuticals' CEO selling 15,202 shares, and Lattice Semiconductor's SVP, CFO selling 16,465 shares.
May 23, 2024 | 12:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
First Solar's Chief People and Comm. Officer sold 12,406 shares at $205 each, totaling $2.54 million. Piper Sandler recently raised its price target for FSLR from $195 to $219.
The insider sale might indicate concerns about the stock's valuation despite the recent price target increase by Piper Sandler.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Lattice Semiconductor's SVP, CFO sold 16,465 shares at $71.98 each, totaling $1.19 million. Needham analyst recently reiterated a Buy rating with an $80 price target.
The insider sale might indicate concerns about the stock's valuation despite the Buy rating and $80 price target from Needham.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Schlumberger's President New Energy sold 38,083 shares at $48.28 each, totaling $1.84 million. The company reported strong Q1 sales on April 19.
Despite strong Q1 sales, the insider sale could signal concerns about future performance or stock overvaluation.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Vertex Pharmaceuticals' CEO sold 15,202 shares at $447 each, totaling $6.8 million. The company posted strong Q1 results on May 6.
The insider sale might indicate concerns about the stock's valuation despite the strong Q1 results.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100